License agreement provides Université de Montréal access to CRISPR gene editing technology for use across its platform services Dublin, Ireland, and Montreal, Canada: ERS Genomics Limited (‘ERS’), the CRISPR licensing Company, and Université de Montréal (‘UdeM’), a leading Canadian research institution renowned for scientific innovation and technology transfer, today announced a non-exclusive CRISPR/Cas9 license agreement. The agreement grants […]

Next generation of industry-leading Cyto-Mine platform will offer new capabilities to optimize single-cell analysis workflow efficiency Opens up new, multiplexed assays and applications for antibody discovery and cell line development, and allows entry into new markets such as cell and gene therapy Cambridge, UK: Sphere Fluidics, a leading provider of innovative droplet-based microfluidics solutions for single-cell […]

PLEASANTON, Calif. — At the Human Cell Atlas General Meeting held September 29-30 in Milan, Italy, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, shared new details about its upcoming product roadmap and its ongoing strategy to democratize access to single cell analysis. During its Foundational Sponsor talk in the Sept. 29 Technology […]

Non-exclusive license includes HiFi DNA Polymerase, HiTemp Reverse Transcriptase, HiRev Isothermal Polymerase and other enzymes for genomics and diagnostic applications REDWOOD CITY, Calif. — Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it has entered into a non-exclusive commercial and manufacturing license agreement with Alphazyme LLC, part of Maravai LifeSciences, for multiple […]

The new lab will leverage PacBio’s HiFi sequencing technology to broaden access to highly accurate long-read sequencing and multi-omics solutions in Southeast Asia SINGAPORE — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, in collaboration with the Agency for Science, Technology, and Research (A*STAR), and Macrogen, today announced the opening of a […]

New microscope enables researchers to use NanoLuc® Luciferase to observe protein dynamics and cellular physiology in live cells, in real time Bioluminescence imaging allows for use of a single luminescent reporter throughout workflow Instrument will be demonstrated at Society for Neuroscience (SFN) 2024 meeting in Chicago, October 5-9 Madison, WI USA. — Promega Corporation, a […]

The Innovation Hub located in Songdo, Incheon will encompass a manufacturing facility and customer experience lab. Operations of the manufacturing facility are anticipated to begin in 2026, with a focus on producing high-quality filtration products. Cytiva, a global life sciences leader, has opened its first Innovation Hub in Korea, located in the Songdo Bio-cluster in […]

The nanopore sequencing pilot programme aims to expand our understanding of the causes of rare genetic disease and cancer and evaluate potential for future routine clinical use. Oxford Nanopore Technologies is entering into a strategic collaboration with UMC Utrecht, one of the leading academic medical centres in the Netherlands, that will aim to explore the […]

Illumina Is the genomic sequencing partner for Otsuka Pharmaceutical Japan’s blood cancer assay HemeSight®, the first-in-Japan comprehensive genomic profiling assay for blood cancer, recently received its first regulatory approval. ‘We are very pleased with the approval of HemeSight in Japan. As Otsuka Pharmaceutical’s technology partner for genomic sequencing, we are proud to support Otsuka and […]

BILLERICA, Mass. – Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced it is making its Simoa® p-Tau 217 Planar Kit commercially available as part of the next phase of Alzheimer’s Disease (AD) test development. The kit uses p-Tau 217 antibody technology licensed from Eli Lilly and […]